#YTHDF2
“The role of m6A reader YTHDF2 in lymphangiogenesis via RNF43/WNT5B in oral squamous cell carcinoma”

🔵 Xin-hua Liang‘s latest research is now available to read in #Oncogenesis.

▶️ Read the full open access article here: www.nature.com/articles/s41...
November 17, 2026 at 9:16 AM
Check how this study establishes YTHDF2 as a multifunctional oncogene in OSCC, driving tumor aggressiveness through dual mechanisms: 1) enhancing the invasive and metastatic potential of OSCC cells, and 2) promoting lymphangiogenesis and lymphatic endothelial cell migration.
November 17, 2026 at 9:17 AM
YTHDF2 Contributes to Postoperative Cognitive Dysfunction Following Femoral Fracture

Molecular neurobiology · Chen et al.
doi.org/10.1007/s12035-026-06305-w
#RNAsky #RNAmods
YTHDF2 Contributes to Postoperative Cognitive Dysfunction Following Femoral Fracture
Molecular neurobiology · Chen J, Liao F, He C, Yang S, Hao Y, Huang J, Fan L, Li H.
doi.org
November 9, 2026 at 10:57 PM
The RNA m6A reader YTHDF2 depletion phenocopies high glucose induced-cellular stress response in diabetic kidney disease https://www.biorxiv.org/content/10.64898/2026.10.23.761296v1
October 27, 2026 at 10:00 AM
The RNA m6A reader YTHDF2 depletion phenocopies high glucose induced-cellular stress response in diabetic kidney disease https://www.biorxiv.org/content/10.64898/2026.10.23.761296v1
October 27, 2026 at 10:00 AM
YTHDF2 regulates pyroptosis and inflammation in ulcerative colitis via modulating CCDC80

Cellular signalling · Wu et al.
doi.org/10.1016/j.cellsig.2026.112968
#RNAsky #RNAmods
YTHDF2 regulates pyroptosis and inflammation in ulcerative colitis via modulating CCDC80
Cellular signalling · Wu W, He H, Wen X, Sun C, Tan W, Li H, Mai S, Ye S, Quan JH, Wu B.
doi.org
October 25, 2026 at 10:59 PM
Mcu upregulation triggers mitochondrial oxidative stress and cardiomyocyte injury after myocardial infarction yet is suppressed by Fto and Ythdf2 in an m6A-dependent manner

Free radical biology & medicine · Chen et al.
doi.org/10.1016/j.freeradbiomed.2026.10.026
#RNAsky #RNAmods
Mcu upregulation triggers mitochondrial oxidative stress and cardiomyocyte injury after myocardial infarction yet is suppressed by Fto and Ythdf2 in an m6A-dependent manner
Free radical biology & medicine · Chen R, Wang X, Qin L, Liu Z, Yu C, Li X, Zhang Z, Yang F, Zhang H, Lan H, Luan X, Xu X, Qu C, Li B, Li G, Chu XM.
doi.org
October 22, 2026 at 11:49 PM
YTHDF2 drives malignant progression in cutaneous melanoma through m⁶A-dependent HMOX1-mediated ferroptosis

Medical oncology (Northwood, London, England) · Gu et al.
doi.org/10.1007/s12032-026-03427-y
#RNAsky #RNAmods
YTHDF2 drives malignant progression in cutaneous melanoma through m⁶A-dependent HMOX1-mediated ferroptosis
Medical oncology (Northwood, London, England) · Gu D, Sun Y, Sun J, Kang W, Lou H, Li X.
doi.org
October 16, 2026 at 11:12 PM
RRIDs were included in this in Nature Communications paper. RRIDs improve reproducibility in scientific research. #methodsmatter #RRID #STMpublishing
POMC neuron METTL14/m6A/YTHDC1/YTHDF2 pathways safeguard energy balance, body weight, and metabolism - Nature Communications
POMC deficiency causes obesity in mice and humans. Here authors uncover a pivotal role of a METTL14/YTHDC1/POMC pathway, an RNA m6A modification-based mechanism, in controlling POMC neurogenesis, POMC expression, and body weight.
doi.org
October 10, 2026 at 7:01 AM
UCSF, 996 participants. In lupus, antibodies against YTHDF2 also bound EBV’s BZLF1 lytic protein, with competition assays showing stronger binding to the viral peptide.

This supports EBV molecular mimicry as a route into autoimmunity.

www.biorxiv.org/content/10.6...
Longitudinal linear-epitope profiling of SLE identifies novel antigens associated with disease and disease activity
Systemic lupus erythematosus (SLE) is the prototypical systemic autoimmune disease defined by the production of autoantibodies directed against diverse self-antigens. Antinuclear antibodies (ANA) are ...
www.biorxiv.org
October 5, 2026 at 11:43 AM
RRID:AB_2687435 from @proteintech.bsky.social was used by authors in their Cell Reports paper. We value the author's support of reproducibility. #OpenScience #OpenResearch #RRID
ZNF121 recruits YTHDF2 to modulate mRNA stability
Read the full paper: ZNF121 recruits YTHDF2 to modulate mRNA stability
doi.org
September 25, 2026 at 7:00 AM
Zearalenone suppresses pituitary follicle-stimulating hormone synthesis via ALKBH5-YTHDF2-SMAD4 axis

Journal of hazardous materials · Liu et al.
doi.org/10.1016/j.jhazmat.2026.143684
#RNAsky #RNAmods
Zearalenone suppresses pituitary follicle-stimulating hormone synthesis via ALKBH5-YTHDF2-SMAD4 axis
In this study, we investigated the molecular mechanism through which ZEA regulates pituitary gonadotropin synthesis via N6‑methyladenosine (m6A) modification.
doi.org
September 23, 2026 at 1:19 PM
Online now: Allosteric modulation of YTHDFs by ellagic acid suppresses triple-negative breast cancer via non-canonical activation of the HIF-1α pathway
Allosteric modulation of YTHDFs by ellagic acid suppresses triple-negative breast cancer via non-canonical activation of the HIF-1α pathway
Zhou et al. identify ellagic acid (EA) as an allosteric inhibitor of YTHDF proteins that binds to a conserved site shared across YTHDF family members. By disrupting YTHDF2-mediated RNA decay, EA stabilizes PFKFB4 mRNA to prevent HIF-1α degradation and upregulates BNIP3 expression, thereby driving triple-negative breast cancer cell death.
dlvr.it
September 21, 2026 at 12:27 PM
Kaempferol attenuates type 2 diabetic osteoporosis via METTL3/YTHDF2-regulated PTEN m⁶A methylation and ferritinophagy-ferroptosis inhibition

Pharmacological research · Huang et al.
doi.org/10.1016/j.phrs.2026.108473
#RNAsky #RNAmods
Kaempferol attenuates type 2 diabetic osteoporosis via METTL3/YTHDF2-regulated PTEN m⁶A methylation and ferritinophagy-ferroptosis inhibition
Pharmacological research · Huang B, Chen J, Jia J, Lin H, Chen X, Guo Y, Chen Z, Su S, Huang C.
doi.org
September 19, 2026 at 1:17 PM
RRID:AB_2687435 from @proteintech.bsky.social was used by authors in their Journal of Biological Chemistry paper. We value the author's support of reproducibility. #STMpublishing #reproducibility #RRID
LAMTOR5 Drives Glioblastoma Progression via Activation of the HOXC9/YTHDF2 Positive Feedback Loop
Read the full paper: LAMTOR5 Drives Glioblastoma Progression via Activation of the HOXC9/YTHDF2 Positive Feedback Loop
doi.org
September 16, 2026 at 7:33 PM
circNfix attenuates acute kidney injury by driving m6A-dependent degradation of YTHDF2 to stabilize DAPK2 mRNA

Clinical science (London, England : 1979) · Ma et al.
doi.org/10.1042/cs20261973
#RNAsky #RNAmods
circNfix attenuates acute kidney injury by driving m6A-dependent degradation of YTHDF2 to stabilize DAPK2 mRNA
Here, we identify a novel mechanism by which the m6A-modified circRNA circNfix contributes to the regulation of septic AKI (SAKI).
doi.org
September 16, 2026 at 1:19 PM
A small chemical mark on RNA helps selected messages reach distant axons in developing neurons. The tag is read by YTHDF2 and linked to transport machinery. doi.org/hcjhp4
RNA 'delivery tags' guide key messages to distant neuron branches
Much like a courier reading an address on a package, neurons must deliver RNA to the precise locations where it is needed.
phys.org
September 14, 2026 at 1:00 PM
LAMTOR5 Drives Glioblastoma Progression via Activation of the HOXC9/YTHDF2 Positive Feedback Loop

The Journal of biological chemistry · Shi et al.
doi.org/10.1016/j.jbc.2026.113528
#RNAsky #RNAmods
LAMTOR5 Drives Glioblastoma Progression via Activation of the HOXC9/YTHDF2 Positive Feedback Loop
We show that LAMTOR5 is a driver gene for glioblastoma progression through transcriptionally activating the HOXC9/YTHDF2 positive feedback loop.
doi.org
September 9, 2026 at 9:06 PM
METTL18-catalyzed histidine methylation of YTHDF2 promotes mRNA stability

Science China. Life sciences · Yang et al.
doi.org/10.1007/s11427-025-3420-3
#RNAsky #RNAmods
METTL18-catalyzed histidine methylation of YTHDF2 promotes mRNA stability
Science China. Life sciences · Yang WL, Liu MX, Han Y, Li XX, Gu Y, Tian X, Mu M, Zhang X, Wang Y, Li X, Chen YS, Gao CC, Lai W, Li A, Li J, Hao Y, Wan
doi.org
September 2, 2026 at 2:03 AM
New study suggests YTHDF2 might have dual reader capacity for m5C and m6A. Would be an interesting read
www.cell.com/cell/fulltex...
YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies
YTHDF2 modulates oncogenic transformation and immune evasion across multiple B cell cancers by stabilizing m5C-modified mRNAs and destabilizing m6A-modified mRNAs, thereby serving as a dual reader for...
www.cell.com
January 23, 2025 at 10:29 PM
Paper in Cell finds that YTHDF2 degrades CD19 and MHC II mRNA while promoting ATP synthesis in B cell malignancies. Could be a mediator of resistance to CD19-targeted therapies.
YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies
@cellcellpress.bsky.social @zhenhuachen.bsky.social
www.cell.com/cell/fulltex...
December 17, 2024 at 8:00 PM
The m6A reader protein YTHDF2 facilitates HTLV-1 infectious and mitotic propagation by stabilizing Tax RNA journals.asm.org/doi/10.1128/...
The m6A reader protein YTHDF2 facilitates HTLV-1 infectious and mitotic propagation by stabilizing Tax RNA | Journal of Virology
m6A is an RNA modification that plays crucial roles in physiological and pathological conditions; however, its roles in HTLV-1 infection are poorly understood. In this study, we identified that m6A mo...
journals.asm.org
May 15, 2026 at 1:22 PM
Structural Elucidation of a Novel Arabinogalactoglucan from Polygonum multiflorum and Its Binding to the m6A Reader YTHDF2
#glycotime #CarbohydrateResearch
Structural Elucidation of a Novel Arabinogalactoglucan from <em>Polygonum multiflorum</em> and Its Binding to the m<sup>6</sup>A Reader YTHDF2
text/html; charset=UTF-8
www.sciencedirect.com
June 10, 2026 at 2:50 PM
#PublicationSpotlight 🔦

Why Are Some Cancer Cells Resistant to CAR-T Therapy?
Publication: YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies:

www.cell.com/cell/abstrac...

#WhenYouNeedItAll Proteintech is here to support your journey to publication success.
YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies
YTHDF2 modulates oncogenic transformation and immune evasion across multiple B cell cancers by stabilizing m5C-modified mRNAs and destabilizing m6A-modified mRNAs, thereby serving as a dual reader for both m5C and m6A modifications. Small molecules that target YTHDF2 reduce ATP synthesis and are therapeutic candidates for B cell malignancies, especially when combined with CAR-T therapy or bispecific engagers.
ow.ly
January 10, 2025 at 11:05 AM